ACCUGENOMICS, INC.

ACCUGENOMICS, INC. specializes in advanced genomic analysis and molecular diagnostics services, leveraging next-generation sequencing technologies and bioinformatics pipelines to support scientific and regulatory objectives. The company’s core capabilities center on high-throughput DNA/RNA sequencing, variant calling, gene expression profiling, and data interpretation for research and compliance-driven applications. With expertise in laboratory information management systems (LIMS) and standardized genomic data formats such as FASTQ, BAM, and VCF, ACCUGENOMICS delivers reproducible, audit-ready results tailored to federal research and public health requirements. Their technical differentiation lies in integrating validated analytical workflows with quality control protocols aligned with CLIA and CAP principles, ensuring data integrity for mission-critical applications. Award history is not available to confirm specific agency engagements, and no recent contract data has been provided to infer relationship patterns or mission alignment. Consequently, agency experience cannot be characterized based on the information provided. The primary NAICS code 325413 corresponds to biological product manufacturing, indicating the company operates within the biotechnology manufacturing sector, likely producing or processing genomic reagents, reference materials, or diagnostic kits. This positions ACCUGENOMICS in the life sciences supply chain, supporting R&D and analytical services for government-funded biomedical initiatives. ACCUGENOMICS, INC. is a small business structured as a 2L entity, with its operational base in Wilmington, North Carolina. The company holds no government certifications, and its market presence is defined by its technical specialization in genomic services rather than formal socio-economic designations. Its geographic footprint is limited to its headquarters location, suggesting a focused, niche operational model within the federal biotech and research services market.